Scarring alopecia, also known as cicatricial alopecia, is a group of rare and complex hair loss disorders characterized by the destruction of hair follicles and subsequent replacement with scar tissue. Unlike non-scarring forms of alopecia, such as androgenetic alopecia (pattern hair loss) or telogen effluvium (temporary shedding), scarring alopecia represents a more severe and irreversible form of hair loss.
Scarring alopecia encompasses various subtypes, each with distinct clinical features, causes, and progression patterns. Although relatively uncommon, it can affect individuals of any age, gender, or ethnic background. Both men and women can be affected by scarring alopecia, with some subtypes showing a predilection for specific groups.
The distinguishing feature of scarring alopecia is the destruction of hair follicles, which are the small structures within the skin responsible for producing and maintaining hair growth. As scar tissue replaces the follicles, the hair cannot regrow, leading to permanent hair loss in affected areas. The scalp is the most affected site, but scarring alopecia can also involve other regions of the body, including the eyebrows, beard, or even the entire body.
Epidemiology
Prevalence: The prevalence of scarring alopecia is relatively low compared to other forms of hair loss. The exact prevalence rates can vary based on geographic location and population studied. Overall, scarring alopecia is a rare condition.
Age and Gender: Scarring alopecia can affect individuals of all ages, including children and adults. However, certain subtypes may have distinct age distributions. For example, frontal fibrosing alopecia (FFA) predominantly affects postmenopausal women, while central centrifugal cicatricial alopecia (CCCA) is more common in African-American women.
Ethnicity: Some subtypes of scarring alopecia have been found to have a higher prevalence in certain ethnic groups. For instance, CCCA is more commonly seen in individuals of African descent, while lichen planopilaris (LPP) and discoid lupus erythematosus (DLE) are more prevalent in individuals of European ancestry.
Risk Factors: several factors may contribute to its development. These can include genetic predisposition, autoimmune processes, chronic inflammation, and environmental triggers. Additionally, certain medications, infections, and trauma to the scalp have been associated with specific subtypes of scarring alopecia.
Anatomy
Pathophysiology
Inflammation: Inflammation plays a crucial role in scarring alopecia. The underlying cause may trigger an inflammatory response in the scalp, leading to damage to the hair follicles. Inflammatory cells, such as lymphocytes and neutrophils, infiltrate the affected areas and release various cytokines, chemokines, and other mediators that contribute to tissue destruction.
Fibrosis: Chronic inflammation in scarring alopecia triggers the activation of fibroblasts, which are responsible for producing collagen and other extracellular matrix components.
Disruption of hair follicle cycle: Hair growth occurs in cycles, including the anagen (growth), catagen (transition), and telogen (resting) phases. In scarring alopecia, the inflammatory process interferes with the normal hair follicle cycle. It can prematurely induce the transition of hair follicles from the anagen to the catagen phase or directly cause follicle miniaturization, leading to shortened or absent anagen phases and ultimately permanent hair loss.
Etiology
Autoimmune Disorders: Certain autoimmune conditions, such as lichen planopilaris, discoid lupus erythematosus, and frontal fibrosing alopecia, are known to cause scarring alopecia.
Inflammatory Skin Conditions: Inflammatory skin diseases like folliculitis decalvans, dissecting cellulitis, and acne keloidalis nuchae can result in scarring alopecia. These conditions involve chronic inflammation of the hair follicles, leading to their destruction and replacement with scar tissue.
Infections: Certain infectious agents, such as bacteria (e.g., Staphylococcus aureus) and viruses (e.g., herpes simplex), have been implicated in scarring alopecia. These infections can trigger an immune response that damages the hair follicles and causes scarring.
Trauma: Physical trauma to the scalp, such as burns, injuries, or surgery, can lead to scarring alopecia. The trauma disrupts the normal structure and function of the hair follicles, resulting in their replacement with scar tissue.
Genetic Predisposition: Some forms of scarring alopecia have a genetic component, suggesting a hereditary predisposition. For example, central centrifugal cicatricial alopecia (CCCA) is more common in individuals of African descent and is believed to have a genetic basis.
Environmental Factors: Exposure to certain environmental triggers, such as chemicals, irritants, or radiation, may contribute to the development of scarring alopecia in susceptible individuals. For instance, exposure to certain hair products, like hair dyes or relaxers, has been associated with some forms of scarring alopecia.
Genetics
Prognostic Factors
The literature lacks thorough validation of the natural progression of scarring alopecia. Previous studies have examined the morbidity associated with alopecia.
Furthermore, the relationship between scarring alopecia and systemic disease has gained significance in research and warrants further investigation, including its potential impact on psychiatric morbidity.
Clinical History
Age Group:
In children, scarring alopecia caused by autoimmune diseases, and infections. Some examples of scarring alopecia conditions that can affect children are lichen planopilaris, discoid lupus erythematosus, and central centrifugal cicatricial alopecia.
In adults, scarring alopecia is often associated with autoimmune disorders, such as lichen planopilaris, frontal fibrosing alopecia, and folliculitis decalvans. Other causes can include trauma, burns, radiation therapy, or certain medications. Age-related factors such as hormonal changes and the natural aging process can also contribute to scarring alopecia in adults.
In the elderly population, scarring alopecia can occur due to various causes, including long-standing autoimmune conditions, infectious diseases, or the cumulative effects of other factors over time. Conditions such as pseudopelade of Brocq and erosive pustular dermatosis can be more prevalent in older individuals.
Physical Examination
Hair examination: The quality and characteristics of the remaining hair are assessed. The hair strands may appear fragile, broken, or sparse. Additionally, the examiner may evaluate the hair shafts under a microscope to identify any structural abnormalities.
Follicular orifice examination: The openings of hair follicles are examined closely to look for signs of scarring or damage. In scarring alopecia, the follicular openings may be absent or destroyed, resulting in a smooth or shiny appearance.
Distribution pattern: The pattern of hair loss is observed to determine if it follows a particular distribution, such as a specific area of the scalp or a symmetrical pattern. This observation can help identify the type and cause of scarring alopecia.
Scalp biopsy: In some cases, a scalp biopsy may be recommended to confirm the diagnosis. A small sample of scalp tissue is extracted and examined under a microscope to evaluate the presence of inflammation, scarring, or other specific features indicative of scarring alopecia.
Dermoscopy: Dermoscopy involves using a specialized magnifying instrument to examine the scalp and hair follicles.
Age group
Associated comorbidity
Associated Comorbidity or Activity:
Autoimmune diseases: Certain types of scarring alopecia, such as lichen planopilaris and discoid lupus erythematosus, are believed to have an autoimmune component. These conditions can be associated with other autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, or thyroid disorders.
Genetic factors: Some forms of scarring alopecia have a genetic component. For example, frontal fibrosing alopecia (FFA) is more common in postmenopausal women and has been associated with a family history of androgenetic alopecia (pattern hair loss).
Trauma or injury: Physical trauma, including burns, accidents, or surgical procedures involving the scalp, can lead to scarring alopecia in the affected areas.
Infection: Certain infections, such as bacterial or fungal infections of the scalp, can cause inflammation and subsequent scarring alopecia.
Hair treatments: Repeated use of harsh chemicals, such as certain hair dyes or relaxers, or excessive heat styling can damage the hair follicles and contribute to scarring alopecia.
Associated activity
Acuity of presentation
The acuity of presentation of scarring alopecia can vary depending on the underlying cause and the individual’s specific circumstances. Scarring alopecia, also known as cicatricial alopecia, is a type of hair loss characterized by the destruction of hair follicles and subsequent replacement with scar tissue. It is important to note that scarring alopecia is typically irreversible, and the hair loss it causes is permanent.
The onset of scarring alopecia can be acute or gradual, depending on the underlying cause. In some cases, it may present suddenly, with rapid hair loss occurring over a relatively short period. This acute presentation is often seen in conditions such as lichen planopilaris or frontal fibrosing alopecia.
Differential Diagnoses
Discoid Lupus Erythematosus (DLE): DLE is an autoimmune condition that primarily affects the skin. It can lead to scarring alopecia, typically characterized by well-defined round or oval patches of hair loss with scaling, erythema, and atrophy. The presence of skin lesions elsewhere on the body can help in the diagnosis.
Lichen Planopilaris (LPP): LPP is a type of primary scarring alopecia characterized by flat-topped, violaceous papules and plaques on the scalp. It often leads to permanent hair loss and scarring. Biopsy findings such as lymphocytic inflammation around the hair follicles and the presence of a lichenoid infiltrate aid in diagnosis.
Frontal Fibrosing Alopecia (FFA): FFA primarily affects postmenopausal women and is characterized by symmetrical hairline recession, eyebrow loss, and occasionally body hair loss. The frontal hairline is typically scarred, and biopsy findings show lymphocytic inflammation around the hair follicles.
Central Centrifugal Cicatricial Alopecia (CCCA): Primarily affecting women of African descent, CCCA involves progressive hair loss starting at the crown and spreading centrifugally. The affected areas often display scarring, follicular dropout, and pustules. Traction or chemical trauma may contribute to its development.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Topical corticosteroids: They are typically applied directly to the scalp in the form of creams, ointments, or gels.
Systemic corticosteroids: In more severe cases, oral or injectable corticosteroids may be prescribed to control the inflammation. These medications have more widespread effects throughout the body and are usually used for a limited period due to their potential side effects.
Topical immunomodulators: Medications such as tacrolimus or pimecrolimus may be prescribed to modulate the immune response and reduce inflammation in the affected area.
Antibiotics or antifungal medications: In cases where an infection is present or suspected, antibiotics or antifungal drugs may be prescribed to treat the underlying infection and minimize further damage to the hair follicles.
Phototherapy: Light therapy, such as ultraviolet (UV) light treatment or laser therapy, may be used to suppress the immune response and reduce inflammation in the scalp.
Hair transplantation: In some cases, when the disease is stable or inactive, hair transplantation procedures may be considered to restore hair in areas of scarring. However, it’s important to note that scarring alopecia can make transplantation challenging, and the success of the procedure may vary.
Scalp Massage: Regularly massaging the scalp with gentle circular motions can help improve blood circulation and promote a healthy scalp environment. This can potentially enhance the delivery of nutrients to the hair follicles and aid in scalp health.
Hair Care Routine: Opt for mild, sulfate-free shampoos and conditioners to avoid any potential irritation or damage to the scalp. Additionally, it’s important to handle the hair gently, avoiding excessive pulling or tight hairstyles that can cause further trauma to the scalp.
Scalp Protection: Sun exposure can worsen inflammation and damage the scalp further, so it’s important to shield it from harmful UV rays.
Stress Management: Stress can exacerbate many health conditions, including hair loss. Employ stress management techniques such as exercise, meditation, or counseling to help reduce stress levels and promote overall well-being.
Avoid harsh hair products: Opt for mild, fragrance-free, and hypoallergenic hair products. Avoid products containing alcohol, sulfates, and strong chemicals that may irritate the scalp and exacerbate scarring alopecia.
Avoid smoking and excessive alcohol consumption: Quit smoking and limit alcohol consumption to support your overall health and hair condition.
Maintain a healthy diet: Eating a well-balanced diet can support overall hair health. Include a variety of nutrient-rich foods such as fruits, vegetables, lean proteins, whole grains, and healthy fats. Essential nutrients for hair health include vitamins A, C, D, E, B-complex vitamins, iron, zinc, and omega-3 fatty acids.
Hydration: Drink an adequate amount of water to keep your body hydrated, which is essential for healthy hair growth.
Use of Immunosuppressants for treating lichen planopilaris
Mycophenolate mofetil: This oral immunosuppressant is another option for treating LPP. It suppresses the activity of certain immune cells involved in the inflammatory response. Mycophenolate mofetil is generally well-tolerated, but regular monitoring is required to assess its effectiveness and potential side effects.
Cyclosporine: Cyclosporine is an oral immunosuppressant that can be considered for severe or refractory cases of LPP. It works by suppressing the immune system’s response, but its use is usually limited to short-term treatment due to potential side effects, including kidney damage and increased susceptibility to infections.
Use of Corticosteroid for treating Lichen planopilaris
Corticosteroids: These medications, such as prednisone or triamcinolone, are potent anti-inflammatory drugs that can be given orally or injected directly into the affected areas. They help reduce inflammation, relieve itching, and halt further hair loss. However, long-term use of corticosteroids can have side effects, so they are usually used for short-term treatment or in combination with other medications.Â
Â
Use of Topical corticosteroids and Tetracycline for treating Central centrifugal cicatricial alopecia
Topical Corticosteroids: They are often prescribed as a first-line treatment for CCCA. Topical corticosteroids are available in various forms, such as creams, ointments, lotions, or foams.Â
Tetracycline: Tetracycline is an antibiotic and is believed to help reduce inflammation and prevent secondary bacterial infections that can worsen the condition.Tetracycline is typically prescribed in its oral form, such as doxycycline or minocycline.
Use of topical steroids and topical antibiotics for treating Acne Keloidalis
Topical Steroids: Steroids have anti-inflammatory properties and can help reduce the inflammation associated with acne keloidalis. They can help alleviate symptoms such as itching, pain, and redness. Topical steroids are available in different strengths, and the specific formulation and potency will depend on the severity of the condition and individual factors. It’s important to follow the prescribed dosage and duration of use to avoid potential side effects, such as thinning of the skin or steroid-induced acne.
Topical Antibiotics: Antibiotics can be used to control the bacterial component of acne keloidalis. Topical antibiotics, such as clindamycin or erythromycin, are commonly prescribed. They work by inhibiting the growth of bacteria on the skin and reducing inflammation. However, it’s worth noting that long-term use of topical antibiotics can contribute to antibiotic resistance, so they are typically used for a limited period.
Use of antistaphylococcal agents for treating Acne necrotica
Topical medications: Topical retinoids, such as tretinoin or adapalene, can help normalize skin cell turnover, reduce inflammation, and prevent clogged pores. Topical antibiotics, such as clindamycin or erythromycin, may be used in combination with retinoids to target both bacteria and inflammation.
Intervention with a procedure
Hair Transplant: In cases where there is no active inflammation and the scarring process has stabilized, hair transplantation may be an option. Healthy hair follicles are harvested from donor areas and transplanted into the scarred regions.
Scalp reduction or tissue expansion: These procedures involve surgically removing scarred tissue and stretching the healthy scalp to cover the affected areas. They are typically considered in more extensive cases of scarring alopecia.
Laser therapy: Low-level laser therapy (LLLT) or red light therapy may be used to stimulate hair growth and reduce inflammation in the scalp.
evaluation-and-diagnosis
Medical history: The dermatologist will gather information about your symptoms, family history, medications, and any relevant medical conditions.
Physical examination: The scalp and hair will be carefully examined to assess the extent and pattern of hair loss, as well as any signs of inflammation or scarring.
Scalp biopsy: A small sample of the affected scalp tissue may be taken for laboratory analysis to confirm the diagnosis and identify the specific type of scarring alopecia.
Treatment of Underlying Cause:
Addressing inflammation: If inflammation is present, the primary goal is to reduce it. Topical or systemic corticosteroids, immunosuppressants, or other anti-inflammatory medications may be prescribed.
Treating infection: If an infection is identified, appropriate antimicrobial or antifungal agents will be prescribed.
Management of autoimmune diseases: For scarring alopecia associated with autoimmune diseases, such as lichen planopilaris or discoid lupus erythematosus, treatments may include oral immunosuppressive medications or other disease-specific therapies.
Scarring alopecia, also known as cicatricial alopecia, is a group of rare and complex hair loss disorders characterized by the destruction of hair follicles and subsequent replacement with scar tissue. Unlike non-scarring forms of alopecia, such as androgenetic alopecia (pattern hair loss) or telogen effluvium (temporary shedding), scarring alopecia represents a more severe and irreversible form of hair loss.
Scarring alopecia encompasses various subtypes, each with distinct clinical features, causes, and progression patterns. Although relatively uncommon, it can affect individuals of any age, gender, or ethnic background. Both men and women can be affected by scarring alopecia, with some subtypes showing a predilection for specific groups.
The distinguishing feature of scarring alopecia is the destruction of hair follicles, which are the small structures within the skin responsible for producing and maintaining hair growth. As scar tissue replaces the follicles, the hair cannot regrow, leading to permanent hair loss in affected areas. The scalp is the most affected site, but scarring alopecia can also involve other regions of the body, including the eyebrows, beard, or even the entire body.
Prevalence: The prevalence of scarring alopecia is relatively low compared to other forms of hair loss. The exact prevalence rates can vary based on geographic location and population studied. Overall, scarring alopecia is a rare condition.
Age and Gender: Scarring alopecia can affect individuals of all ages, including children and adults. However, certain subtypes may have distinct age distributions. For example, frontal fibrosing alopecia (FFA) predominantly affects postmenopausal women, while central centrifugal cicatricial alopecia (CCCA) is more common in African-American women.
Ethnicity: Some subtypes of scarring alopecia have been found to have a higher prevalence in certain ethnic groups. For instance, CCCA is more commonly seen in individuals of African descent, while lichen planopilaris (LPP) and discoid lupus erythematosus (DLE) are more prevalent in individuals of European ancestry.
Risk Factors: several factors may contribute to its development. These can include genetic predisposition, autoimmune processes, chronic inflammation, and environmental triggers. Additionally, certain medications, infections, and trauma to the scalp have been associated with specific subtypes of scarring alopecia.
Inflammation: Inflammation plays a crucial role in scarring alopecia. The underlying cause may trigger an inflammatory response in the scalp, leading to damage to the hair follicles. Inflammatory cells, such as lymphocytes and neutrophils, infiltrate the affected areas and release various cytokines, chemokines, and other mediators that contribute to tissue destruction.
Fibrosis: Chronic inflammation in scarring alopecia triggers the activation of fibroblasts, which are responsible for producing collagen and other extracellular matrix components.
Disruption of hair follicle cycle: Hair growth occurs in cycles, including the anagen (growth), catagen (transition), and telogen (resting) phases. In scarring alopecia, the inflammatory process interferes with the normal hair follicle cycle. It can prematurely induce the transition of hair follicles from the anagen to the catagen phase or directly cause follicle miniaturization, leading to shortened or absent anagen phases and ultimately permanent hair loss.
Autoimmune Disorders: Certain autoimmune conditions, such as lichen planopilaris, discoid lupus erythematosus, and frontal fibrosing alopecia, are known to cause scarring alopecia.
Inflammatory Skin Conditions: Inflammatory skin diseases like folliculitis decalvans, dissecting cellulitis, and acne keloidalis nuchae can result in scarring alopecia. These conditions involve chronic inflammation of the hair follicles, leading to their destruction and replacement with scar tissue.
Infections: Certain infectious agents, such as bacteria (e.g., Staphylococcus aureus) and viruses (e.g., herpes simplex), have been implicated in scarring alopecia. These infections can trigger an immune response that damages the hair follicles and causes scarring.
Trauma: Physical trauma to the scalp, such as burns, injuries, or surgery, can lead to scarring alopecia. The trauma disrupts the normal structure and function of the hair follicles, resulting in their replacement with scar tissue.
Genetic Predisposition: Some forms of scarring alopecia have a genetic component, suggesting a hereditary predisposition. For example, central centrifugal cicatricial alopecia (CCCA) is more common in individuals of African descent and is believed to have a genetic basis.
Environmental Factors: Exposure to certain environmental triggers, such as chemicals, irritants, or radiation, may contribute to the development of scarring alopecia in susceptible individuals. For instance, exposure to certain hair products, like hair dyes or relaxers, has been associated with some forms of scarring alopecia.
The literature lacks thorough validation of the natural progression of scarring alopecia. Previous studies have examined the morbidity associated with alopecia.
Furthermore, the relationship between scarring alopecia and systemic disease has gained significance in research and warrants further investigation, including its potential impact on psychiatric morbidity.
Age Group:
In children, scarring alopecia caused by autoimmune diseases, and infections. Some examples of scarring alopecia conditions that can affect children are lichen planopilaris, discoid lupus erythematosus, and central centrifugal cicatricial alopecia.
In adults, scarring alopecia is often associated with autoimmune disorders, such as lichen planopilaris, frontal fibrosing alopecia, and folliculitis decalvans. Other causes can include trauma, burns, radiation therapy, or certain medications. Age-related factors such as hormonal changes and the natural aging process can also contribute to scarring alopecia in adults.
In the elderly population, scarring alopecia can occur due to various causes, including long-standing autoimmune conditions, infectious diseases, or the cumulative effects of other factors over time. Conditions such as pseudopelade of Brocq and erosive pustular dermatosis can be more prevalent in older individuals.
Hair examination: The quality and characteristics of the remaining hair are assessed. The hair strands may appear fragile, broken, or sparse. Additionally, the examiner may evaluate the hair shafts under a microscope to identify any structural abnormalities.
Follicular orifice examination: The openings of hair follicles are examined closely to look for signs of scarring or damage. In scarring alopecia, the follicular openings may be absent or destroyed, resulting in a smooth or shiny appearance.
Distribution pattern: The pattern of hair loss is observed to determine if it follows a particular distribution, such as a specific area of the scalp or a symmetrical pattern. This observation can help identify the type and cause of scarring alopecia.
Scalp biopsy: In some cases, a scalp biopsy may be recommended to confirm the diagnosis. A small sample of scalp tissue is extracted and examined under a microscope to evaluate the presence of inflammation, scarring, or other specific features indicative of scarring alopecia.
Dermoscopy: Dermoscopy involves using a specialized magnifying instrument to examine the scalp and hair follicles.
Associated Comorbidity or Activity:
Autoimmune diseases: Certain types of scarring alopecia, such as lichen planopilaris and discoid lupus erythematosus, are believed to have an autoimmune component. These conditions can be associated with other autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, or thyroid disorders.
Genetic factors: Some forms of scarring alopecia have a genetic component. For example, frontal fibrosing alopecia (FFA) is more common in postmenopausal women and has been associated with a family history of androgenetic alopecia (pattern hair loss).
Trauma or injury: Physical trauma, including burns, accidents, or surgical procedures involving the scalp, can lead to scarring alopecia in the affected areas.
Infection: Certain infections, such as bacterial or fungal infections of the scalp, can cause inflammation and subsequent scarring alopecia.
Hair treatments: Repeated use of harsh chemicals, such as certain hair dyes or relaxers, or excessive heat styling can damage the hair follicles and contribute to scarring alopecia.
The acuity of presentation of scarring alopecia can vary depending on the underlying cause and the individual’s specific circumstances. Scarring alopecia, also known as cicatricial alopecia, is a type of hair loss characterized by the destruction of hair follicles and subsequent replacement with scar tissue. It is important to note that scarring alopecia is typically irreversible, and the hair loss it causes is permanent.
The onset of scarring alopecia can be acute or gradual, depending on the underlying cause. In some cases, it may present suddenly, with rapid hair loss occurring over a relatively short period. This acute presentation is often seen in conditions such as lichen planopilaris or frontal fibrosing alopecia.
Discoid Lupus Erythematosus (DLE): DLE is an autoimmune condition that primarily affects the skin. It can lead to scarring alopecia, typically characterized by well-defined round or oval patches of hair loss with scaling, erythema, and atrophy. The presence of skin lesions elsewhere on the body can help in the diagnosis.
Lichen Planopilaris (LPP): LPP is a type of primary scarring alopecia characterized by flat-topped, violaceous papules and plaques on the scalp. It often leads to permanent hair loss and scarring. Biopsy findings such as lymphocytic inflammation around the hair follicles and the presence of a lichenoid infiltrate aid in diagnosis.
Frontal Fibrosing Alopecia (FFA): FFA primarily affects postmenopausal women and is characterized by symmetrical hairline recession, eyebrow loss, and occasionally body hair loss. The frontal hairline is typically scarred, and biopsy findings show lymphocytic inflammation around the hair follicles.
Central Centrifugal Cicatricial Alopecia (CCCA): Primarily affecting women of African descent, CCCA involves progressive hair loss starting at the crown and spreading centrifugally. The affected areas often display scarring, follicular dropout, and pustules. Traction or chemical trauma may contribute to its development.
Topical corticosteroids: They are typically applied directly to the scalp in the form of creams, ointments, or gels.
Systemic corticosteroids: In more severe cases, oral or injectable corticosteroids may be prescribed to control the inflammation. These medications have more widespread effects throughout the body and are usually used for a limited period due to their potential side effects.
Topical immunomodulators: Medications such as tacrolimus or pimecrolimus may be prescribed to modulate the immune response and reduce inflammation in the affected area.
Antibiotics or antifungal medications: In cases where an infection is present or suspected, antibiotics or antifungal drugs may be prescribed to treat the underlying infection and minimize further damage to the hair follicles.
Phototherapy: Light therapy, such as ultraviolet (UV) light treatment or laser therapy, may be used to suppress the immune response and reduce inflammation in the scalp.
Hair transplantation: In some cases, when the disease is stable or inactive, hair transplantation procedures may be considered to restore hair in areas of scarring. However, it’s important to note that scarring alopecia can make transplantation challenging, and the success of the procedure may vary.
Physical Medicine and Rehabilitation
Scalp Massage: Regularly massaging the scalp with gentle circular motions can help improve blood circulation and promote a healthy scalp environment. This can potentially enhance the delivery of nutrients to the hair follicles and aid in scalp health.
Hair Care Routine: Opt for mild, sulfate-free shampoos and conditioners to avoid any potential irritation or damage to the scalp. Additionally, it’s important to handle the hair gently, avoiding excessive pulling or tight hairstyles that can cause further trauma to the scalp.
Scalp Protection: Sun exposure can worsen inflammation and damage the scalp further, so it’s important to shield it from harmful UV rays.
Stress Management: Stress can exacerbate many health conditions, including hair loss. Employ stress management techniques such as exercise, meditation, or counseling to help reduce stress levels and promote overall well-being.
Avoid harsh hair products: Opt for mild, fragrance-free, and hypoallergenic hair products. Avoid products containing alcohol, sulfates, and strong chemicals that may irritate the scalp and exacerbate scarring alopecia.
Avoid smoking and excessive alcohol consumption: Quit smoking and limit alcohol consumption to support your overall health and hair condition.
Nutrition
Maintain a healthy diet: Eating a well-balanced diet can support overall hair health. Include a variety of nutrient-rich foods such as fruits, vegetables, lean proteins, whole grains, and healthy fats. Essential nutrients for hair health include vitamins A, C, D, E, B-complex vitamins, iron, zinc, and omega-3 fatty acids.
Hydration: Drink an adequate amount of water to keep your body hydrated, which is essential for healthy hair growth.
Dermatology, General
Mycophenolate mofetil: This oral immunosuppressant is another option for treating LPP. It suppresses the activity of certain immune cells involved in the inflammatory response. Mycophenolate mofetil is generally well-tolerated, but regular monitoring is required to assess its effectiveness and potential side effects.
Cyclosporine: Cyclosporine is an oral immunosuppressant that can be considered for severe or refractory cases of LPP. It works by suppressing the immune system’s response, but its use is usually limited to short-term treatment due to potential side effects, including kidney damage and increased susceptibility to infections.
Dermatology, General
Corticosteroids: These medications, such as prednisone or triamcinolone, are potent anti-inflammatory drugs that can be given orally or injected directly into the affected areas. They help reduce inflammation, relieve itching, and halt further hair loss. However, long-term use of corticosteroids can have side effects, so they are usually used for short-term treatment or in combination with other medications.Â
Â
Dermatology, General
Topical Corticosteroids: They are often prescribed as a first-line treatment for CCCA. Topical corticosteroids are available in various forms, such as creams, ointments, lotions, or foams.Â
Tetracycline: Tetracycline is an antibiotic and is believed to help reduce inflammation and prevent secondary bacterial infections that can worsen the condition.Tetracycline is typically prescribed in its oral form, such as doxycycline or minocycline.
Dermatology, General
Topical Steroids: Steroids have anti-inflammatory properties and can help reduce the inflammation associated with acne keloidalis. They can help alleviate symptoms such as itching, pain, and redness. Topical steroids are available in different strengths, and the specific formulation and potency will depend on the severity of the condition and individual factors. It’s important to follow the prescribed dosage and duration of use to avoid potential side effects, such as thinning of the skin or steroid-induced acne.
Topical Antibiotics: Antibiotics can be used to control the bacterial component of acne keloidalis. Topical antibiotics, such as clindamycin or erythromycin, are commonly prescribed. They work by inhibiting the growth of bacteria on the skin and reducing inflammation. However, it’s worth noting that long-term use of topical antibiotics can contribute to antibiotic resistance, so they are typically used for a limited period.
Dermatology, General
Topical medications: Topical retinoids, such as tretinoin or adapalene, can help normalize skin cell turnover, reduce inflammation, and prevent clogged pores. Topical antibiotics, such as clindamycin or erythromycin, may be used in combination with retinoids to target both bacteria and inflammation.
Intervention with a procedure
Hair Transplant: In cases where there is no active inflammation and the scarring process has stabilized, hair transplantation may be an option. Healthy hair follicles are harvested from donor areas and transplanted into the scarred regions.
Scalp reduction or tissue expansion: These procedures involve surgically removing scarred tissue and stretching the healthy scalp to cover the affected areas. They are typically considered in more extensive cases of scarring alopecia.
Laser therapy: Low-level laser therapy (LLLT) or red light therapy may be used to stimulate hair growth and reduce inflammation in the scalp.
Dermatology, General
Medical history: The dermatologist will gather information about your symptoms, family history, medications, and any relevant medical conditions.
Physical examination: The scalp and hair will be carefully examined to assess the extent and pattern of hair loss, as well as any signs of inflammation or scarring.
Scalp biopsy: A small sample of the affected scalp tissue may be taken for laboratory analysis to confirm the diagnosis and identify the specific type of scarring alopecia.
Treatment of Underlying Cause:
Addressing inflammation: If inflammation is present, the primary goal is to reduce it. Topical or systemic corticosteroids, immunosuppressants, or other anti-inflammatory medications may be prescribed.
Treating infection: If an infection is identified, appropriate antimicrobial or antifungal agents will be prescribed.
Management of autoimmune diseases: For scarring alopecia associated with autoimmune diseases, such as lichen planopilaris or discoid lupus erythematosus, treatments may include oral immunosuppressive medications or other disease-specific therapies.
Scarring alopecia, also known as cicatricial alopecia, is a group of rare and complex hair loss disorders characterized by the destruction of hair follicles and subsequent replacement with scar tissue. Unlike non-scarring forms of alopecia, such as androgenetic alopecia (pattern hair loss) or telogen effluvium (temporary shedding), scarring alopecia represents a more severe and irreversible form of hair loss.
Scarring alopecia encompasses various subtypes, each with distinct clinical features, causes, and progression patterns. Although relatively uncommon, it can affect individuals of any age, gender, or ethnic background. Both men and women can be affected by scarring alopecia, with some subtypes showing a predilection for specific groups.
The distinguishing feature of scarring alopecia is the destruction of hair follicles, which are the small structures within the skin responsible for producing and maintaining hair growth. As scar tissue replaces the follicles, the hair cannot regrow, leading to permanent hair loss in affected areas. The scalp is the most affected site, but scarring alopecia can also involve other regions of the body, including the eyebrows, beard, or even the entire body.
Prevalence: The prevalence of scarring alopecia is relatively low compared to other forms of hair loss. The exact prevalence rates can vary based on geographic location and population studied. Overall, scarring alopecia is a rare condition.
Age and Gender: Scarring alopecia can affect individuals of all ages, including children and adults. However, certain subtypes may have distinct age distributions. For example, frontal fibrosing alopecia (FFA) predominantly affects postmenopausal women, while central centrifugal cicatricial alopecia (CCCA) is more common in African-American women.
Ethnicity: Some subtypes of scarring alopecia have been found to have a higher prevalence in certain ethnic groups. For instance, CCCA is more commonly seen in individuals of African descent, while lichen planopilaris (LPP) and discoid lupus erythematosus (DLE) are more prevalent in individuals of European ancestry.
Risk Factors: several factors may contribute to its development. These can include genetic predisposition, autoimmune processes, chronic inflammation, and environmental triggers. Additionally, certain medications, infections, and trauma to the scalp have been associated with specific subtypes of scarring alopecia.
Inflammation: Inflammation plays a crucial role in scarring alopecia. The underlying cause may trigger an inflammatory response in the scalp, leading to damage to the hair follicles. Inflammatory cells, such as lymphocytes and neutrophils, infiltrate the affected areas and release various cytokines, chemokines, and other mediators that contribute to tissue destruction.
Fibrosis: Chronic inflammation in scarring alopecia triggers the activation of fibroblasts, which are responsible for producing collagen and other extracellular matrix components.
Disruption of hair follicle cycle: Hair growth occurs in cycles, including the anagen (growth), catagen (transition), and telogen (resting) phases. In scarring alopecia, the inflammatory process interferes with the normal hair follicle cycle. It can prematurely induce the transition of hair follicles from the anagen to the catagen phase or directly cause follicle miniaturization, leading to shortened or absent anagen phases and ultimately permanent hair loss.
Autoimmune Disorders: Certain autoimmune conditions, such as lichen planopilaris, discoid lupus erythematosus, and frontal fibrosing alopecia, are known to cause scarring alopecia.
Inflammatory Skin Conditions: Inflammatory skin diseases like folliculitis decalvans, dissecting cellulitis, and acne keloidalis nuchae can result in scarring alopecia. These conditions involve chronic inflammation of the hair follicles, leading to their destruction and replacement with scar tissue.
Infections: Certain infectious agents, such as bacteria (e.g., Staphylococcus aureus) and viruses (e.g., herpes simplex), have been implicated in scarring alopecia. These infections can trigger an immune response that damages the hair follicles and causes scarring.
Trauma: Physical trauma to the scalp, such as burns, injuries, or surgery, can lead to scarring alopecia. The trauma disrupts the normal structure and function of the hair follicles, resulting in their replacement with scar tissue.
Genetic Predisposition: Some forms of scarring alopecia have a genetic component, suggesting a hereditary predisposition. For example, central centrifugal cicatricial alopecia (CCCA) is more common in individuals of African descent and is believed to have a genetic basis.
Environmental Factors: Exposure to certain environmental triggers, such as chemicals, irritants, or radiation, may contribute to the development of scarring alopecia in susceptible individuals. For instance, exposure to certain hair products, like hair dyes or relaxers, has been associated with some forms of scarring alopecia.
The literature lacks thorough validation of the natural progression of scarring alopecia. Previous studies have examined the morbidity associated with alopecia.
Furthermore, the relationship between scarring alopecia and systemic disease has gained significance in research and warrants further investigation, including its potential impact on psychiatric morbidity.
Age Group:
In children, scarring alopecia caused by autoimmune diseases, and infections. Some examples of scarring alopecia conditions that can affect children are lichen planopilaris, discoid lupus erythematosus, and central centrifugal cicatricial alopecia.
In adults, scarring alopecia is often associated with autoimmune disorders, such as lichen planopilaris, frontal fibrosing alopecia, and folliculitis decalvans. Other causes can include trauma, burns, radiation therapy, or certain medications. Age-related factors such as hormonal changes and the natural aging process can also contribute to scarring alopecia in adults.
In the elderly population, scarring alopecia can occur due to various causes, including long-standing autoimmune conditions, infectious diseases, or the cumulative effects of other factors over time. Conditions such as pseudopelade of Brocq and erosive pustular dermatosis can be more prevalent in older individuals.
Hair examination: The quality and characteristics of the remaining hair are assessed. The hair strands may appear fragile, broken, or sparse. Additionally, the examiner may evaluate the hair shafts under a microscope to identify any structural abnormalities.
Follicular orifice examination: The openings of hair follicles are examined closely to look for signs of scarring or damage. In scarring alopecia, the follicular openings may be absent or destroyed, resulting in a smooth or shiny appearance.
Distribution pattern: The pattern of hair loss is observed to determine if it follows a particular distribution, such as a specific area of the scalp or a symmetrical pattern. This observation can help identify the type and cause of scarring alopecia.
Scalp biopsy: In some cases, a scalp biopsy may be recommended to confirm the diagnosis. A small sample of scalp tissue is extracted and examined under a microscope to evaluate the presence of inflammation, scarring, or other specific features indicative of scarring alopecia.
Dermoscopy: Dermoscopy involves using a specialized magnifying instrument to examine the scalp and hair follicles.
Associated Comorbidity or Activity:
Autoimmune diseases: Certain types of scarring alopecia, such as lichen planopilaris and discoid lupus erythematosus, are believed to have an autoimmune component. These conditions can be associated with other autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, or thyroid disorders.
Genetic factors: Some forms of scarring alopecia have a genetic component. For example, frontal fibrosing alopecia (FFA) is more common in postmenopausal women and has been associated with a family history of androgenetic alopecia (pattern hair loss).
Trauma or injury: Physical trauma, including burns, accidents, or surgical procedures involving the scalp, can lead to scarring alopecia in the affected areas.
Infection: Certain infections, such as bacterial or fungal infections of the scalp, can cause inflammation and subsequent scarring alopecia.
Hair treatments: Repeated use of harsh chemicals, such as certain hair dyes or relaxers, or excessive heat styling can damage the hair follicles and contribute to scarring alopecia.
The acuity of presentation of scarring alopecia can vary depending on the underlying cause and the individual’s specific circumstances. Scarring alopecia, also known as cicatricial alopecia, is a type of hair loss characterized by the destruction of hair follicles and subsequent replacement with scar tissue. It is important to note that scarring alopecia is typically irreversible, and the hair loss it causes is permanent.
The onset of scarring alopecia can be acute or gradual, depending on the underlying cause. In some cases, it may present suddenly, with rapid hair loss occurring over a relatively short period. This acute presentation is often seen in conditions such as lichen planopilaris or frontal fibrosing alopecia.
Discoid Lupus Erythematosus (DLE): DLE is an autoimmune condition that primarily affects the skin. It can lead to scarring alopecia, typically characterized by well-defined round or oval patches of hair loss with scaling, erythema, and atrophy. The presence of skin lesions elsewhere on the body can help in the diagnosis.
Lichen Planopilaris (LPP): LPP is a type of primary scarring alopecia characterized by flat-topped, violaceous papules and plaques on the scalp. It often leads to permanent hair loss and scarring. Biopsy findings such as lymphocytic inflammation around the hair follicles and the presence of a lichenoid infiltrate aid in diagnosis.
Frontal Fibrosing Alopecia (FFA): FFA primarily affects postmenopausal women and is characterized by symmetrical hairline recession, eyebrow loss, and occasionally body hair loss. The frontal hairline is typically scarred, and biopsy findings show lymphocytic inflammation around the hair follicles.
Central Centrifugal Cicatricial Alopecia (CCCA): Primarily affecting women of African descent, CCCA involves progressive hair loss starting at the crown and spreading centrifugally. The affected areas often display scarring, follicular dropout, and pustules. Traction or chemical trauma may contribute to its development.
Topical corticosteroids: They are typically applied directly to the scalp in the form of creams, ointments, or gels.
Systemic corticosteroids: In more severe cases, oral or injectable corticosteroids may be prescribed to control the inflammation. These medications have more widespread effects throughout the body and are usually used for a limited period due to their potential side effects.
Topical immunomodulators: Medications such as tacrolimus or pimecrolimus may be prescribed to modulate the immune response and reduce inflammation in the affected area.
Antibiotics or antifungal medications: In cases where an infection is present or suspected, antibiotics or antifungal drugs may be prescribed to treat the underlying infection and minimize further damage to the hair follicles.
Phototherapy: Light therapy, such as ultraviolet (UV) light treatment or laser therapy, may be used to suppress the immune response and reduce inflammation in the scalp.
Hair transplantation: In some cases, when the disease is stable or inactive, hair transplantation procedures may be considered to restore hair in areas of scarring. However, it’s important to note that scarring alopecia can make transplantation challenging, and the success of the procedure may vary.
Physical Medicine and Rehabilitation
Scalp Massage: Regularly massaging the scalp with gentle circular motions can help improve blood circulation and promote a healthy scalp environment. This can potentially enhance the delivery of nutrients to the hair follicles and aid in scalp health.
Hair Care Routine: Opt for mild, sulfate-free shampoos and conditioners to avoid any potential irritation or damage to the scalp. Additionally, it’s important to handle the hair gently, avoiding excessive pulling or tight hairstyles that can cause further trauma to the scalp.
Scalp Protection: Sun exposure can worsen inflammation and damage the scalp further, so it’s important to shield it from harmful UV rays.
Stress Management: Stress can exacerbate many health conditions, including hair loss. Employ stress management techniques such as exercise, meditation, or counseling to help reduce stress levels and promote overall well-being.
Avoid harsh hair products: Opt for mild, fragrance-free, and hypoallergenic hair products. Avoid products containing alcohol, sulfates, and strong chemicals that may irritate the scalp and exacerbate scarring alopecia.
Avoid smoking and excessive alcohol consumption: Quit smoking and limit alcohol consumption to support your overall health and hair condition.
Nutrition
Maintain a healthy diet: Eating a well-balanced diet can support overall hair health. Include a variety of nutrient-rich foods such as fruits, vegetables, lean proteins, whole grains, and healthy fats. Essential nutrients for hair health include vitamins A, C, D, E, B-complex vitamins, iron, zinc, and omega-3 fatty acids.
Hydration: Drink an adequate amount of water to keep your body hydrated, which is essential for healthy hair growth.
Dermatology, General
Mycophenolate mofetil: This oral immunosuppressant is another option for treating LPP. It suppresses the activity of certain immune cells involved in the inflammatory response. Mycophenolate mofetil is generally well-tolerated, but regular monitoring is required to assess its effectiveness and potential side effects.
Cyclosporine: Cyclosporine is an oral immunosuppressant that can be considered for severe or refractory cases of LPP. It works by suppressing the immune system’s response, but its use is usually limited to short-term treatment due to potential side effects, including kidney damage and increased susceptibility to infections.
Dermatology, General
Corticosteroids: These medications, such as prednisone or triamcinolone, are potent anti-inflammatory drugs that can be given orally or injected directly into the affected areas. They help reduce inflammation, relieve itching, and halt further hair loss. However, long-term use of corticosteroids can have side effects, so they are usually used for short-term treatment or in combination with other medications.Â
Â
Dermatology, General
Topical Corticosteroids: They are often prescribed as a first-line treatment for CCCA. Topical corticosteroids are available in various forms, such as creams, ointments, lotions, or foams.Â
Tetracycline: Tetracycline is an antibiotic and is believed to help reduce inflammation and prevent secondary bacterial infections that can worsen the condition.Tetracycline is typically prescribed in its oral form, such as doxycycline or minocycline.
Dermatology, General
Topical Steroids: Steroids have anti-inflammatory properties and can help reduce the inflammation associated with acne keloidalis. They can help alleviate symptoms such as itching, pain, and redness. Topical steroids are available in different strengths, and the specific formulation and potency will depend on the severity of the condition and individual factors. It’s important to follow the prescribed dosage and duration of use to avoid potential side effects, such as thinning of the skin or steroid-induced acne.
Topical Antibiotics: Antibiotics can be used to control the bacterial component of acne keloidalis. Topical antibiotics, such as clindamycin or erythromycin, are commonly prescribed. They work by inhibiting the growth of bacteria on the skin and reducing inflammation. However, it’s worth noting that long-term use of topical antibiotics can contribute to antibiotic resistance, so they are typically used for a limited period.
Dermatology, General
Topical medications: Topical retinoids, such as tretinoin or adapalene, can help normalize skin cell turnover, reduce inflammation, and prevent clogged pores. Topical antibiotics, such as clindamycin or erythromycin, may be used in combination with retinoids to target both bacteria and inflammation.
Intervention with a procedure
Hair Transplant: In cases where there is no active inflammation and the scarring process has stabilized, hair transplantation may be an option. Healthy hair follicles are harvested from donor areas and transplanted into the scarred regions.
Scalp reduction or tissue expansion: These procedures involve surgically removing scarred tissue and stretching the healthy scalp to cover the affected areas. They are typically considered in more extensive cases of scarring alopecia.
Laser therapy: Low-level laser therapy (LLLT) or red light therapy may be used to stimulate hair growth and reduce inflammation in the scalp.
Dermatology, General
Medical history: The dermatologist will gather information about your symptoms, family history, medications, and any relevant medical conditions.
Physical examination: The scalp and hair will be carefully examined to assess the extent and pattern of hair loss, as well as any signs of inflammation or scarring.
Scalp biopsy: A small sample of the affected scalp tissue may be taken for laboratory analysis to confirm the diagnosis and identify the specific type of scarring alopecia.
Treatment of Underlying Cause:
Addressing inflammation: If inflammation is present, the primary goal is to reduce it. Topical or systemic corticosteroids, immunosuppressants, or other anti-inflammatory medications may be prescribed.
Treating infection: If an infection is identified, appropriate antimicrobial or antifungal agents will be prescribed.
Management of autoimmune diseases: For scarring alopecia associated with autoimmune diseases, such as lichen planopilaris or discoid lupus erythematosus, treatments may include oral immunosuppressive medications or other disease-specific therapies.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
